Relapsing polychondritis (RP) is a recurrent, chronic und rare disease
of unknown etiology, characterized by inflammation of cartilaginous s
tructures of the ears, nose, respiratory tract and joints. The associa
tion with HLA-DR4 and the occurrence of antibodies to type-II collagen
and other autoantibodies suggest that an immunologic mechanism is inv
olved in its pathogenesis. In about 30% of occurrences RP is associate
d with other rheumatic or autoimmune diseases. Occular inflammation, i
nvolvement of the cardiovascular system, skin, central nervous system
and audiovestibular organ are most probably caused by vasculitis. The
course of RP is variable. Severity and outcome primarily depend on the
occurrence of associated autoimmune diseases and vasculitis. Accordin
g to the activity and systemic manifestations, medical treatment inclu
des nonsteroidal antiinflammatory drugs, corticosteroids and cytotoxic
agents.